SpliceBio

Investments

SpliceBio Raises EUR 50M in oversubscribed Series A financing to advance protein splicing platform and expand gene therapy pipeline

SpliceBio, a biotechnology company exploiting protein splicing to develop next generation gene therapies, today announced the completion of an oversubscribed €50 million series A financing. The financing was co-led by UCB Ventures and existing shareholder Ysios Capital and joined by new investors New Enterprise Associates (NEA), Gilde Healthcare, Novartis Venture Fund, and existing shareholder Asabys […]

This website uses cookies

This Website uses site management and analytics cookies you can further check our cookies policy here and read here how we process your data and how to exercise your rights.
Accept Read More

The below list details the cookies used in our website.

Cookie	Type	Duration	Description
__cfduid	third party	1 year	Used by the contentn etwork, Cloudflare, to identify trusted web traffic.
_ga	third party	2 years	Registers a uniqu e ID that is used to generate statistical data on how the visitor uses the website.
woocommerce_cart_hash	session	session	e-Commerce temporary session
woocommerce_items_in_cart	session	session	e-Commerce temporary session
wp_woocommerce_session_	session	session	e-Commerce temporary session